The challenges in data integration – heterogeneity and complexity in clinical trials and patient registries of Systemic Lupus Erythematosus

Abstract Background Individual clinical trials and cohort studies are a useful source of data, often under-utilised once a study has ended. Pooling data from multiple sources could increase sample sizes and allow for further investigation of treatment effects; even if the original trial did not meet...

Full description

Bibliographic Details
Main Authors: Helen Le Sueur, Ian N. Bruce, Nophar Geifman, on behalf of the MASTERPLANS Consortium
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Medical Research Methodology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12874-020-01057-0
id doaj-93a68d9229444558b897029f84233909
record_format Article
spelling doaj-93a68d9229444558b897029f842339092020-11-25T03:11:36ZengBMCBMC Medical Research Methodology1471-22882020-06-012011510.1186/s12874-020-01057-0The challenges in data integration – heterogeneity and complexity in clinical trials and patient registries of Systemic Lupus ErythematosusHelen Le Sueur0Ian N. Bruce1Nophar Geifman2on behalf of the MASTERPLANS ConsortiumCentre for Health Informatics, Vaughan Housue, Portsmouth St., The University of ManchesterArthritis Research UK Centre for Epidemiology, The University of ManchesterCentre for Health Informatics, Vaughan Housue, Portsmouth St., The University of ManchesterAbstract Background Individual clinical trials and cohort studies are a useful source of data, often under-utilised once a study has ended. Pooling data from multiple sources could increase sample sizes and allow for further investigation of treatment effects; even if the original trial did not meet its primary goals. Through the MASTERPLANS (MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches) national consortium, focused on Systemic Lupus Erythematosus (SLE), we have gained valuable real-world experiences in aligning, harmonising and combining data from multiple studies and trials, specifically where standards for data capture, representation and documentation, were not used or were unavailable. This was not without challenges arising both from the inherent complexity of the disease and from differences in the way data were captured and represented across different studies. Main body Data were, unavoidably, aligned by hand, matching up equivalent or similar patient variables across the different studies. Heterogeneity-related issues were tackled and data were cleaned, organised and combined, resulting in a single large dataset ready for analysis. Overcoming these hurdles, often seen in large-scale data harmonization and integration endeavours of legacy datasets, was made possible within a realistic timescale and limited resource by focusing on specific research questions driven by the aims of MASTERPLANS. Here we describe our experiences tackling the complexities in the integration of large, diverse datasets, and the lessons learned. Conclusions Harmonising data across studies can be complex, and time and resource consuming. The work carried out here highlights the importance of using standards for data capture, recording, and representation, to facilitate both the integration of large datasets and comparison between studies. Where standards are not implemented at the source harmonisation is still possible by taking a flexible approach, with systematic preparation, and a focus on specific research questions.http://link.springer.com/article/10.1186/s12874-020-01057-0Data integrationData harmonisationClinical trialsLupusPooled analysis
collection DOAJ
language English
format Article
sources DOAJ
author Helen Le Sueur
Ian N. Bruce
Nophar Geifman
on behalf of the MASTERPLANS Consortium
spellingShingle Helen Le Sueur
Ian N. Bruce
Nophar Geifman
on behalf of the MASTERPLANS Consortium
The challenges in data integration – heterogeneity and complexity in clinical trials and patient registries of Systemic Lupus Erythematosus
BMC Medical Research Methodology
Data integration
Data harmonisation
Clinical trials
Lupus
Pooled analysis
author_facet Helen Le Sueur
Ian N. Bruce
Nophar Geifman
on behalf of the MASTERPLANS Consortium
author_sort Helen Le Sueur
title The challenges in data integration – heterogeneity and complexity in clinical trials and patient registries of Systemic Lupus Erythematosus
title_short The challenges in data integration – heterogeneity and complexity in clinical trials and patient registries of Systemic Lupus Erythematosus
title_full The challenges in data integration – heterogeneity and complexity in clinical trials and patient registries of Systemic Lupus Erythematosus
title_fullStr The challenges in data integration – heterogeneity and complexity in clinical trials and patient registries of Systemic Lupus Erythematosus
title_full_unstemmed The challenges in data integration – heterogeneity and complexity in clinical trials and patient registries of Systemic Lupus Erythematosus
title_sort challenges in data integration – heterogeneity and complexity in clinical trials and patient registries of systemic lupus erythematosus
publisher BMC
series BMC Medical Research Methodology
issn 1471-2288
publishDate 2020-06-01
description Abstract Background Individual clinical trials and cohort studies are a useful source of data, often under-utilised once a study has ended. Pooling data from multiple sources could increase sample sizes and allow for further investigation of treatment effects; even if the original trial did not meet its primary goals. Through the MASTERPLANS (MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches) national consortium, focused on Systemic Lupus Erythematosus (SLE), we have gained valuable real-world experiences in aligning, harmonising and combining data from multiple studies and trials, specifically where standards for data capture, representation and documentation, were not used or were unavailable. This was not without challenges arising both from the inherent complexity of the disease and from differences in the way data were captured and represented across different studies. Main body Data were, unavoidably, aligned by hand, matching up equivalent or similar patient variables across the different studies. Heterogeneity-related issues were tackled and data were cleaned, organised and combined, resulting in a single large dataset ready for analysis. Overcoming these hurdles, often seen in large-scale data harmonization and integration endeavours of legacy datasets, was made possible within a realistic timescale and limited resource by focusing on specific research questions driven by the aims of MASTERPLANS. Here we describe our experiences tackling the complexities in the integration of large, diverse datasets, and the lessons learned. Conclusions Harmonising data across studies can be complex, and time and resource consuming. The work carried out here highlights the importance of using standards for data capture, recording, and representation, to facilitate both the integration of large datasets and comparison between studies. Where standards are not implemented at the source harmonisation is still possible by taking a flexible approach, with systematic preparation, and a focus on specific research questions.
topic Data integration
Data harmonisation
Clinical trials
Lupus
Pooled analysis
url http://link.springer.com/article/10.1186/s12874-020-01057-0
work_keys_str_mv AT helenlesueur thechallengesindataintegrationheterogeneityandcomplexityinclinicaltrialsandpatientregistriesofsystemiclupuserythematosus
AT iannbruce thechallengesindataintegrationheterogeneityandcomplexityinclinicaltrialsandpatientregistriesofsystemiclupuserythematosus
AT nophargeifman thechallengesindataintegrationheterogeneityandcomplexityinclinicaltrialsandpatientregistriesofsystemiclupuserythematosus
AT onbehalfofthemasterplansconsortium thechallengesindataintegrationheterogeneityandcomplexityinclinicaltrialsandpatientregistriesofsystemiclupuserythematosus
AT helenlesueur challengesindataintegrationheterogeneityandcomplexityinclinicaltrialsandpatientregistriesofsystemiclupuserythematosus
AT iannbruce challengesindataintegrationheterogeneityandcomplexityinclinicaltrialsandpatientregistriesofsystemiclupuserythematosus
AT nophargeifman challengesindataintegrationheterogeneityandcomplexityinclinicaltrialsandpatientregistriesofsystemiclupuserythematosus
AT onbehalfofthemasterplansconsortium challengesindataintegrationheterogeneityandcomplexityinclinicaltrialsandpatientregistriesofsystemiclupuserythematosus
_version_ 1724653393979375616